I agree that this site is using cookies. You can find further informations here.
X
Topalian, Suzanne L
100  results:
OpenAccess-fulltext X
Search for persons X
?
1

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in ..:

Rosner, Samuel ; Reuss, Joshua E ; Zahurak, Marianna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932577/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Combinatorial biomarker for predicting outcomes to anti-PD-..:

Deutsch, Julie Stein ; Lipson, Evan J ; Danilova, Ludmila...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975323/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Proceedings From the ASCO/College of American Pathologists ..:

Hayes, Daniel F ; Herbst, Roy S ; Myles, Jonathan L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530621/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Three-year survival, correlates and salvage therapies in pa..:

Nghiem, Paul ; Bhatia, Shailender ; Lipson, Evan J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061836/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Conserved Interferon-γ Signaling Drives Clinical Response t..:

Grasso, Catherine S ; Tsoi, Jennifer ; Onyshchenko, Mykola...
qt21w7t4w2.  , 2021
Link: https://escholarship.org..
 
?
6

Neoadjuvant nivolumab for patients with resectable HPV-posi..:

Ferris, Robert L ; Spanos, William C ; Leidner, Rom...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183204/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Three-year survival, correlates and salvage therapies in pa..:

Nghiem, Paul ; Bhatia, Shailender ; Lipson, Evan J...
qt87f8b7bn.  , 2021
Link: https://escholarship.org..
 
?
8

Conserved interferon-γ signaling drives clinical response t..:

Grasso, Catherine S ; Tsoi, Jennifer ; Onyshchenko, Mykola...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872287/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Defining tumor resistance to PD-1 pathway blockade: recomme..:

Kluger, Harriet M ; Tawbi, Hussein A ; Ascierto, Maria L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174063/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Integrative Tumor and Immune Cell Multi-omic Analyses Predi..:

Anagnostou, Valsamo ; Bruhm, Daniel C ; Niknafs, Noushin...
qt8r85066j.  , 2020
Link: https://escholarship.org..
 
?
11

Integrative Tumor and Immune Cell Multi-omic Analyses Predi..:

Anagnostou, Valsamo ; Bruhm, Daniel C ; Niknafs, Noushin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691441/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Neoadjuvant checkpoint blockade for cancer immunotherapy:

Topalian, Suzanne L ; Taube, Janis M ; Pardoll, Drew M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789854/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

The genetic evolution of treatment-resistant cutaneous, acr..:

Makohon-Moore, Alvin P ; Lipson, Evan J ; Hooper, Jody E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925434/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Neoadjuvant Nivolumab for Patients With Resectable Merkel C..:

Topalian, Suzanne L ; Bhatia, Shailender ; Amin, Asim...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392746/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Conserved Interferon-γ Signaling Drives Clinical Response t..:

Grasso, Catherine S ; Tsoi, Jennifer ; Onyshchenko, Mykola...
qt1p746628.  , 2020
Link: https://escholarship.org..
 
1-15